Marianna Mancini, Chief Operating Officer at Viking Therapeutics, Inc. (VKTX), sold 562,850 shares at $76.40 ($44.3M) on 2024-05-01, disclosed to the SEC on 2024-05-02.
Scheduled sale ($44.3M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.40 | 23,746 | $1.8M | 4.1% |
| 2 | $76.40 | 23,746 | $1.8M | 4.1% |
| 3 | $77.49 | 26,142 | $2.0M | 4.6% |
| 4 | $77.49 | 26,142 | $2.0M | 4.6% |
| 5 | $78.65 | 105,343 | $8.3M | 18.7% |
| 6 | $78.65 | 105,343 |
| $8.3M |
| 18.7% |
| 7 | $79.29 | 119,946 | $9.5M | 21.5% |
| 8 | $79.29 | 119,946 | $9.5M | 21.5% |
| 9 | $80.08 | 6,248 | $500K | 1.1% |
| 10 | $80.08 | 6,248 | $500K | 1.1% |
| Total | $78.66 avg | 562,850 | $44.3M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $216K | — | Filing → |
| VKTX | SELL | 2025-07-03 | $237K | — | Filing → |
| VKTX | SELL | 2025-01-06 | $4.4M | — | Filing → |